148 related articles for article (PubMed ID: 35460613)
21. Structural rationale for the recognition of arginine at P₃ in PEXEL motif containing proteins of Plasmodium falciparum by plasmepsin V.
Guruprasad L; Tanneeru K; Guruprasad K
Protein Pept Lett; 2011 Jun; 18(6):634-41. PubMed ID: 21342099
[TBL] [Abstract][Full Text] [Related]
22. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.
Silva AM; Lee AY; Gulnik SV; Maier P; Collins J; Bhat TN; Collins PJ; Cachau RE; Luker KE; Gluzman IY; Francis SE; Oksman A; Goldberg DE; Erickson JW
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10034-9. PubMed ID: 8816746
[TBL] [Abstract][Full Text] [Related]
23. The zymogen of plasmepsin V from Plasmodium falciparum is enzymatically active.
Xiao H; Bryksa BC; Bhaumik P; Gustchina A; Kiso Y; Yao SQ; Wlodawer A; Yada RY
Mol Biochem Parasitol; 2014 Oct; 197(1-2):56-63. PubMed ID: 25447707
[TBL] [Abstract][Full Text] [Related]
24. Plasmodium falciparum, P. vivax, and P. malariae: a comparison of the active site properties of plasmepsins cloned and expressed from three different species of the malaria parasite.
Westling J; Yowell CA; Majer P; Erickson JW; Dame JB; Dunn BM
Exp Parasitol; 1997 Nov; 87(3):185-93. PubMed ID: 9371083
[TBL] [Abstract][Full Text] [Related]
25. Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme.
Kesari P; Deshmukh A; Pahelkar N; Suryawanshi AB; Rathore I; Mishra V; Dupuis JH; Xiao H; Gustchina A; Abendroth J; Labaied M; Yada RY; Wlodawer A; Edwards TE; Lorimer DD; Bhaumik P
Protein Sci; 2022 Apr; 31(4):882-899. PubMed ID: 35048450
[TBL] [Abstract][Full Text] [Related]
26. Predicting functional residues in Plasmodium falciparum plasmepsins by combining sequence and structural analysis with molecular dynamics simulations.
Valiente PA; Batista PR; Pupo A; Pons T; Valencia A; Pascutti PG
Proteins; 2008 Nov; 73(2):440-57. PubMed ID: 18442137
[TBL] [Abstract][Full Text] [Related]
27. Sequence homology and structural analysis of plasmepsin 4 isolated from Indian Plasmodium vivax isolates.
Rawat M; Vijay S; Gupta Y; Dixit R; Tiwari PK; Sharma A
Infect Genet Evol; 2011 Jul; 11(5):924-33. PubMed ID: 21382523
[TBL] [Abstract][Full Text] [Related]
28. Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria.
Andrews KT; Fairlie DP; Madala PK; Ray J; Wyatt DM; Hilton PM; Melville LA; Beattie L; Gardiner DL; Reid RC; Stoermer MJ; Skinner-Adams T; Berry C; McCarthy JS
Antimicrob Agents Chemother; 2006 Feb; 50(2):639-48. PubMed ID: 16436721
[TBL] [Abstract][Full Text] [Related]
29. New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins.
Jiang S; Prigge ST; Wei L; Gao Ye ; Hudson TH; Gerena L; Dame JB; Kyle DE
Antimicrob Agents Chemother; 2001 Sep; 45(9):2577-84. PubMed ID: 11502532
[TBL] [Abstract][Full Text] [Related]
30. Malaria parasite plasmepsins: More than just plain old degradative pepsins.
Nasamu AS; Polino AJ; Istvan ES; Goldberg DE
J Biol Chem; 2020 Jun; 295(25):8425-8441. PubMed ID: 32366462
[TBL] [Abstract][Full Text] [Related]
31. Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum.
Asojo OA; Gulnik SV; Afonina E; Yu B; Ellman JA; Haque TS; Silva AM
J Mol Biol; 2003 Mar; 327(1):173-81. PubMed ID: 12614616
[TBL] [Abstract][Full Text] [Related]
32. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
[TBL] [Abstract][Full Text] [Related]
33. Structures of plasmepsin II from Plasmodium falciparum in complex with two hydroxyethylamine-based inhibitors.
Recacha R; Leitans J; Akopjana I; Aprupe L; Trapencieris P; Jaudzems K; Jirgensons A; Tars K
Acta Crystallogr F Struct Biol Commun; 2015 Dec; 71(Pt 12):1531-9. PubMed ID: 26625296
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of Plasmodium falciparum proplasmepsin IV: the plasticity of proplasmepsins.
Recacha R; Jaudzems K; Akopjana I; Jirgensons A; Tars K
Acta Crystallogr F Struct Biol Commun; 2016 Sep; 72(Pt 9):659-66. PubMed ID: 27599854
[TBL] [Abstract][Full Text] [Related]
35. Targeting Plasmodium Proteases to Block Malaria Parasite Escape and Entry.
Paul AS; Duraisingh MT
Trends Parasitol; 2018 Feb; 34(2):95-97. PubMed ID: 29269028
[TBL] [Abstract][Full Text] [Related]
36. Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium berghei.
Liu P; Robbins AH; Marzahn MR; McClung SH; Yowell CA; Stevens SM; Dame JB; Dunn BM
PLoS One; 2015; 10(10):e0141758. PubMed ID: 26510189
[TBL] [Abstract][Full Text] [Related]
37. Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of
Lowe MA; Cardenas A; Valentin JP; Zhu Z; Abendroth J; Castro JL; Class R; Delaunois A; Fleurance R; Gerets H; Gryshkova V; King L; Lorimer DD; MacCoss M; Rowley JH; Rosseels ML; Royer L; Taylor RD; Wong M; Zaccheo O; Chavan VP; Ghule GA; Tapkir BK; Burrows JN; Duffey M; Rottmann M; Wittlin S; Angulo-Barturen I; Jiménez-Díaz MB; Striepen J; Fairhurst KJ; Yeo T; Fidock DA; Cowman AF; Favuzza P; Crespo-Fernandez B; Gamo FJ; Goldberg DE; Soldati-Favre D; Laleu B; de Haro T
J Med Chem; 2022 Oct; 65(20):14121-14143. PubMed ID: 36216349
[TBL] [Abstract][Full Text] [Related]
38. Structural insights into the activation of P. vivax plasmepsin.
Bernstein NK; Cherney MM; Yowell CA; Dame JB; James MN
J Mol Biol; 2003 Jun; 329(3):505-24. PubMed ID: 12767832
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target.
Nezami A; Luque I; Kimura T; Kiso Y; Freire E
Biochemistry; 2002 Feb; 41(7):2273-80. PubMed ID: 11841219
[TBL] [Abstract][Full Text] [Related]
40. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
Moura PA; Dame JB; Fidock DA
Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
